Tamura M, Noda M
Department of Molecular Pharmacology, Tokyo Medical and Dental University, Japan.
J Cell Biol. 1994 Aug;126(3):773-82. doi: 10.1083/jcb.126.3.773.
To elucidate regulatory mechanism(s) underlying differentiation of osteoblasts, we examined involvement of helix-loop-helix (HLH)-type transcription factors in osteoblast-specific expression of a phenotypic marker gene which encodes osteocalcin, a major noncollagenous bone matrix protein, exclusively expressed in osteoblasts. Overexpression of a dominant negative HLH protein, Id-1, decreased the activity of the 1.1-kb osteocalcin gene promoter cotransfected into rat osteoblastic osteosarcoma ROS17/2.8 cells. Analysis of deletion mutants revealed that a 264-bp fragment of osteocalcin promoter (-198 to +66) was sufficient for the Id-1-dependent suppression. Furthermore, the activity of the same promoter fragment (-198 to +66) was enhanced when antisense Id-1 expression vector was cotransfected. This osteocalcin gene promoter region contains two sites of an E-box motif, a consensus binding site for HLH proteins, which we refer to as OCE1 (CACATG, at -102) and OCE2 (CAGCTG, at -149), respectively. Mutagenesis in OCE1 but not OCE2 led to greater than 50% reduction in transcriptional activity of the osteocalcin gene promoter. Electrophoresis mobility shift assay indicated that factors in nuclear extracts prepared from ROS17/2.8 cells bound to the 30-bp oligonucleotide probe containing the E-box motif of OCE1. This binding was competed out by OCE1 oligonucleotide but neither by OCmE1 oligonucleotide in which E-box motif was mutated nor by OCE2. The OCE1-binding activity in the nuclear extracts of ROS17/2.8 cells was reduced by 70% when bacterially expressed Id-1 protein was added to the reaction mixture, suggesting the involvement of HLH proteins in the DNA/protein complex formation. In contrast to the osteoblast-like cells, OCE1-binding activity in the nuclear extracts of C3H10T1/2 fibroblasts was very low. However, when these fibroblasts were treated with recombinant human bone morphogenetic protein-2 which induced expression of osteocalcin as well as other phenotypic markers of osteoblasts, OCE1-binding activity was increased approximately 40-fold, indicating that OCE1 would be involved in the tissue-specific expression of the osteocalcin gene. These findings indicated for the first time that osteoblast-specific gene transcription is regulated via the interaction between certain E-box binding transcription factor(s) in osteoblasts and the OCE1 sequence in the promoter region of the osteocalcin gene.
为阐明成骨细胞分化的潜在调控机制,我们研究了螺旋-环-螺旋(HLH)型转录因子在成骨细胞特异性表达一种编码骨钙素的表型标记基因中的作用。骨钙素是一种主要的非胶原蛋白骨基质蛋白,仅在成骨细胞中表达。显性负性HLH蛋白Id-1的过表达降低了共转染到大鼠成骨细胞骨肉瘤ROS17/2.8细胞中的1.1-kb骨钙素基因启动子的活性。缺失突变体分析表明,骨钙素启动子的一个264-bp片段(-198至+66)足以实现Id-1依赖性抑制。此外,当共转染反义Id-1表达载体时,相同启动子片段(-198至+66)的活性增强。该骨钙素基因启动子区域包含两个E-box基序位点,这是HLH蛋白的共有结合位点,我们分别将其称为OCE1(-102处的CACATG)和OCE2(-149处的CAGCTG)。OCE1而非OCE2中的诱变导致骨钙素基因启动子的转录活性降低超过50%。电泳迁移率变动分析表明,从ROS17/2.8细胞制备的核提取物中的因子与包含OCE1的E-box基序的30-bp寡核苷酸探针结合。这种结合被OCE1寡核苷酸竞争,但不被E-box基序突变的OCmE1寡核苷酸或OCE2竞争。当将细菌表达的Id-1蛋白添加到反应混合物中时,ROS17/2.8细胞核提取物中的OCE1结合活性降低了70%,表明HLH蛋白参与了DNA/蛋白质复合物的形成。与成骨样细胞相反,C3H10T1/2成纤维细胞核提取物中的OCE1结合活性非常低。然而,当用重组人骨形态发生蛋白-2处理这些成纤维细胞时,其诱导了骨钙素以及成骨细胞其他表型标记的表达,OCE1结合活性增加了约40倍,表明OCE1参与了骨钙素基因的组织特异性表达。这些发现首次表明,成骨细胞特异性基因转录是通过成骨细胞中某些E-box结合转录因子与骨钙素基因启动子区域中的OCE1序列之间的相互作用来调节的。